168 related articles for article (PubMed ID: 18469310)
1. N-acetylcysteine protects against renal injury following bilateral ureteral obstruction.
Shimizu MH; Danilovic A; Andrade L; Volpini RA; Libório AB; Sanches TR; Seguro AC
Nephrol Dial Transplant; 2008 Oct; 23(10):3067-73. PubMed ID: 18469310
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin prevents the downregulation of aquaporin-2 receptor after bilateral ureteral obstruction and protects renal function in a rat model.
Danilovic A; Lopes RI; Sanches TR; Shimizu MH; Oshiro FM; Andrade L; Dénes FT; Seguro AC
Urology; 2012 Aug; 80(2):485.e15-20. PubMed ID: 22503765
[TBL] [Abstract][Full Text] [Related]
3. Melatonin therapy protects against renal injury before and after release of bilateral ureteral obstruction in rats.
Li Z; Wang Y; Sun N; Liu X; Song E; Zhang Z; Wen J; Zheng T
Life Sci; 2019 Jul; 229():104-115. PubMed ID: 31100324
[TBL] [Abstract][Full Text] [Related]
4. Magnesium supplementation combined with N-acetylcysteine protects against postischemic acute renal failure.
de Araujo M; Andrade L; Coimbra TM; Rodrigues AC; Seguro AC
J Am Soc Nephrol; 2005 Nov; 16(11):3339-49. PubMed ID: 16177005
[TBL] [Abstract][Full Text] [Related]
5. N-acetylcysteine protects against diabetic nephropathy through control of oxidative and nitrosative stress by recovery of nitric oxide in rats.
Nogueira GB; Punaro GR; Oliveira CS; Maciel FR; Fernandes TO; Lima DY; Rodrigues AM; Mouro MG; Araujo SRR; Higa EMS
Nitric Oxide; 2018 Aug; 78():22-31. PubMed ID: 29778909
[TBL] [Abstract][Full Text] [Related]
6. COX-2 activity transiently contributes to increased water and NaCl excretion in the polyuric phase after release of ureteral obstruction.
Nørregaard R; Jensen BL; Topcu SO; Diget M; Schweer H; Knepper MA; Nielsen S; Frøkiaer J
Am J Physiol Renal Physiol; 2007 May; 292(5):F1322-33. PubMed ID: 17229676
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of AQP1, -2, and -3 after ureteral obstruction is associated with a long-term urine-concentrating defect.
Li C; Wang W; Kwon TH; Isikay L; Wen JG; Marples D; Djurhuus JC; Stockwell A; Knepper MA; Nielsen S; Frøkiaer J
Am J Physiol Renal Physiol; 2001 Jul; 281(1):F163-71. PubMed ID: 11399657
[TBL] [Abstract][Full Text] [Related]
8. The renal protect function of erythropoietin after release of bilateral ureteral obstruction in a rat model.
Ren CC; Zhu W; Wang QW; Lu YT; Wang Y; Zhang GX; Xie JF; Wu JW; Jia ZM; Zhang T; Su ZQ; Wen JG
Clin Sci (Lond); 2018 Sep; 132(18):2071-2085. PubMed ID: 29959186
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II mediates downregulation of aquaporin water channels and key renal sodium transporters in response to urinary tract obstruction.
Jensen AM; Li C; Praetorius HA; Nørregaard R; Frische S; Knepper MA; Nielsen S; Frøkiaer J
Am J Physiol Renal Physiol; 2006 Nov; 291(5):F1021-32. PubMed ID: 16757730
[TBL] [Abstract][Full Text] [Related]
10. Role of platelet-activating factor in renal function in normal rats and rats with bilateral ureteral obstruction.
Reyes AA; Klahr S
Proc Soc Exp Biol Med; 1991 Oct; 198(1):572-8. PubMed ID: 1891471
[TBL] [Abstract][Full Text] [Related]
11. EDRF role in renal function and blood pressure of normal rats and rats with obstructive uropathy.
Reyes AA; Martin D; Settle S; Klahr S
Kidney Int; 1992 Feb; 41(2):403-13. PubMed ID: 1552713
[TBL] [Abstract][Full Text] [Related]
12. alpha-MSH prevents impairment in renal function and dysregulation of AQPs and Na-K-ATPase in rats with bilateral ureteral obstruction.
Li C; Shi Y; Wang W; Sardeli C; Kwon TH; Thomsen K; Jonassen T; Djurhuus JC; Knepper MA; Nielsen S; Frøkiaer J
Am J Physiol Renal Physiol; 2006 Feb; 290(2):F384-96. PubMed ID: 16189288
[TBL] [Abstract][Full Text] [Related]
13. [Renal functional reserve in obstructive nephropathy].
Takihana Y; Tago K; Ueno A
Nihon Jinzo Gakkai Shi; 1994 Feb; 36(2):130-7. PubMed ID: 8139145
[TBL] [Abstract][Full Text] [Related]
14. Renal expression and urinary excretion of aquaporin-2 in postobstructive uropathy in rats.
Brandoni A; Torres AM
Can J Physiol Pharmacol; 2021 Jun; 99(6):619-626. PubMed ID: 34048270
[TBL] [Abstract][Full Text] [Related]
15. N-acetylcysteine attenuates the progression of chronic renal failure.
Shimizu MH; Coimbra TM; de Araujo M; Menezes LF; Seguro AC
Kidney Int; 2005 Nov; 68(5):2208-17. PubMed ID: 16221220
[TBL] [Abstract][Full Text] [Related]
16. Role of the 5-lipooxygenase pathway in obstructive nephropathy.
Reyes AA; Lefkowith J; Pippin J; Klahr S
Kidney Int; 1992 Jan; 41(1):100-6. PubMed ID: 1317475
[TBL] [Abstract][Full Text] [Related]
17. Bilateral ureteral obstruction induces early downregulation and redistribution of AQP2 and phosphorylated AQP2.
Stødkilde L; Nørregaard R; Fenton RA; Wang G; Knepper MA; Frøkiær J
Am J Physiol Renal Physiol; 2011 Jul; 301(1):F226-35. PubMed ID: 21525134
[TBL] [Abstract][Full Text] [Related]
18. N-acetylcysteine attenuates renal alterations induced by senescence in the rat.
Shimizu MH; Volpini RA; de Bragança AC; Campos R; Canale D; Sanches TR; Andrade L; Seguro AC
Exp Gerontol; 2013 Feb; 48(2):298-303. PubMed ID: 23183129
[TBL] [Abstract][Full Text] [Related]
19. Effects of acute bilateral ureteral obstruction on deep nephron and terminal collecting duct function in the young rat.
Buerkert J; Head M; Klahr S
J Clin Invest; 1977 Jun; 59(6):1055-65. PubMed ID: 864002
[TBL] [Abstract][Full Text] [Related]
20. Candesartan prevents long-term impairment of renal function in response to neonatal partial unilateral ureteral obstruction.
Topcu SO; Pedersen M; Nørregaard R; Wang G; Knepper M; Djurhuus JC; Nielsen S; Jørgensen TM; Frøkiaer J
Am J Physiol Renal Physiol; 2007 Feb; 292(2):F736-48. PubMed ID: 17032940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
